secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2026-06-04T20:41:02+00:00
Accession:  0001404644-26-000040
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Neurogene stockholders elect directors, approve executive compensation, ratify Deloitte
--------------------------------------------------------------------------------

- Class III directors Robert Baffi (9,540,734 for) and Rohan Palekar (10,058,331 for) elected to three-year terms.
- Non-binding advisory vote on named executive officer compensation passed: 9,991,445 for, 36,394 against.
- Ratification of Deloitte & Touche as auditor for FY 2026 approved: 9,345,925 for, 1,939,039 against.
- Advisory vote on frequency of future compensation votes: 10,006,265 chose one year; company will hold votes annually.
- Quorum of 11,387,407 shares (72.92%) present; meeting held June 3, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000140464426000040/0001404644-26-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000140464426000040/ngne-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001404644-26-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer